Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Poignard

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Plos Pathogens|January 15, 2016
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection CohortElise Landais, Xiayu Huang, Colin Havenar-Daughton, et al.
Nature|August 19, 2011
Broad neutralization coverage of HIV by multiple highly potent antibodiesLaura M Walker, Michael Huber, Katie J Doores, et al.
Immunity|November 23, 2017
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody LineageElise Landais, Ben Murrell, Bryan Briney, et al.
Journal of Virology|May 15, 2009
Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithmMelissa D Simek, Wasima Rida, Frances H Priddy, et al.
Plos Pathogens|March 19, 2013
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognitionDavid Lutje Hulsik, Ying-ying Liu, Nika M Strokappe, et al.
Plos Pathogens|June 29, 2023
Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodiesCollin Joyce, Sasha Murrell, Ben Murrell, et al.
Nature|November 1, 2013
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeysDan H Barouch, James B Whitney, Brian Moldt, et al.
Cell Reports. Medicine|March 2, 2022
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infectionGuidenn Sulbaran, Pauline Maisonnasse, Axelle Amen, et al.
Plos Pathogens|November 27, 2013
The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodiesDevin Sok, Uri Laserson, Jonathan Laserson, et al.
Science (New York, N.Y.)|October 15, 2011
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shieldRobert Pejchal, Katie J Doores, Laura M Walker, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Plos Pathogens|January 15, 2016
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection CohortElise Landais, Xiayu Huang, Colin Havenar-Daughton, et al.
Nature|August 19, 2011
Broad neutralization coverage of HIV by multiple highly potent antibodiesLaura M Walker, Michael Huber, Katie J Doores, et al.
Immunity|November 23, 2017
HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody LineageElise Landais, Ben Murrell, Bryan Briney, et al.
Journal of Virology|May 15, 2009
Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithmMelissa D Simek, Wasima Rida, Frances H Priddy, et al.
Plos Pathogens|March 19, 2013
A gp41 MPER-specific llama VHH requires a hydrophobic CDR3 for neutralization but not for antigen recognitionDavid Lutje Hulsik, Ying-ying Liu, Nika M Strokappe, et al.
Plos Pathogens|June 29, 2023
Antigen pressure from two founder viruses induces multiple insertions at a single antibody position to generate broadly neutralizing HIV antibodiesCollin Joyce, Sasha Murrell, Ben Murrell, et al.
Nature|November 1, 2013
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeysDan H Barouch, James B Whitney, Brian Moldt, et al.
Cell Reports. Medicine|March 2, 2022
Immunization with synthetic SARS-CoV-2 S glycoprotein virus-like particles protects macaques from infectionGuidenn Sulbaran, Pauline Maisonnasse, Axelle Amen, et al.
Plos Pathogens|November 27, 2013
The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodiesDevin Sok, Uri Laserson, Jonathan Laserson, et al.
Science (New York, N.Y.)|October 15, 2011
A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shieldRobert Pejchal, Katie J Doores, Laura M Walker, et al.
Pageof 9